|
|
Volumn 18, Issue 12, 2009, Pages 1997-2004
|
|
Treatment considerations for bacterial vaginosis and the risk of recurrence.
a
a
IQVIA
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
CLINDAMYCIN;
METRONIDAZOLE;
ADOLESCENT;
ADULT;
ARTICLE;
COMPARATIVE STUDY;
DRUG ADMINISTRATION;
FEMALE;
HUMAN;
INTRAVAGINAL DRUG ADMINISTRATION;
MICROBIOLOGY;
MIDDLE AGED;
ORAL DRUG ADMINISTRATION;
RECURRENT DISEASE;
RISK FACTOR;
TREATMENT OUTCOME;
UNITED STATES;
VAGINA;
VAGINA CANDIDIASIS;
VAGINITIS;
WOMEN'S HEALTH;
ADMINISTRATION, INTRAVAGINAL;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
ANTI-BACTERIAL AGENTS;
CANDIDIASIS, VULVOVAGINAL;
CLINDAMYCIN;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
METRONIDAZOLE;
MIDDLE AGED;
RECURRENCE;
RISK FACTORS;
TREATMENT OUTCOME;
UNITED STATES;
VAGINA;
VAGINOSIS, BACTERIAL;
WOMEN'S HEALTH;
YOUNG ADULT;
|
|
EID: 77950345778
PISSN: None
EISSN: 1931843X
Source Type: Journal
DOI: 10.1089/jwh.2008.1088 Document Type: Article |
|
Times cited : (16)
|
|
References (0)
|
